These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 116431)

  • 1. Allo anti-D production in a D positive patient.
    Roycroft DW; Wientjes M; Lovell D; Young VL
    Va Med; 1979 Nov; 106(11):863. PubMed ID: 116431
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved response of an Rh-positive patient with aplastic anemia to donor platelet transfusions with intravenous anti-D rhesus antibodies.
    Siemons L; Colpin G; Muylle L; De Bock R; Peetermans ME
    N Engl J Med; 1987 Dec; 317(26):1667-8. PubMed ID: 3120010
    [No Abstract]   [Full Text] [Related]  

  • 5. [5 cases of hemolytic transfusion reactions induced by anti-E].
    Tong H; Yu R
    Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):476, 486. PubMed ID: 12212124
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of Rh anti-E and anti-c production among Japanese after blood transfusion.
    Komatsu F
    Bull Tokyo Med Dent Univ; 1988 Sep; 35(3):75-9. PubMed ID: 3148374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant and insignificant antibodies in blood transfusion.
    Morel PA; Garratty G; Perkins HA
    Am J Med Technol; 1978 Feb; 44(2):122-9. PubMed ID: 414622
    [No Abstract]   [Full Text] [Related]  

  • 8. CD36 immunization in a patient undergoing hematopoietic stem cell transplantation.
    Culler EE; Hillyer CD; Haight AE; Castillejo MI; Josephson CD
    Pediatr Blood Cancer; 2008 Mar; 50(3):660-2. PubMed ID: 17330834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 10. Cerebrovascular accident during a delayed hemolytic transfusion reaction in a patient with sickle cell anemia.
    Mintz PD; Williams ME
    Ann Clin Lab Sci; 1986; 16(3):214-8. PubMed ID: 3717883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Allo-immunization against antigens from non-D blood groups. Value of detection].
    Mannessier L; Goudemand M; Delecour M
    Lille Med; 1980 Mar; 25(3):90-3. PubMed ID: 6768941
    [No Abstract]   [Full Text] [Related]  

  • 13. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply].
    Meunier N; Rodet M; Bonin P; Chadebech P; Chami B; Lee K; Habibi A; Bachir D; Galactéros F; Bierling P; Noizat-Pirenne F
    Transfus Clin Biol; 2008 Dec; 15(6):377-82. PubMed ID: 19026581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in transfusion of patients with sickle cell disease.
    van Draat KF
    Transfus Apher Sci; 2013 Apr; 48(2):165. PubMed ID: 23809817
    [No Abstract]   [Full Text] [Related]  

  • 16. RH (D)-isoimmunization of Japanese women.
    Hisanaga S; Arakawa K; Hamada T; Taki I
    Acta Obstet Gynaecol Jpn; 1973 Jan; 20(1):34-8. PubMed ID: 4214532
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient presence of an anti-D alloantibody.
    Harrison CR; Evans C
    Arch Pathol Lab Med; 1985 Nov; 109(11):1042-3. PubMed ID: 3931606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual post-transfusion isoimmunization in the Rh and Duffy systems].
    Svanda M; Procházka R
    Vnitr Lek; 1967 Feb; 13(2):161-2. PubMed ID: 4962971
    [No Abstract]   [Full Text] [Related]  

  • 20. RBC alloimmunization in blood transfusion-dependent beta-thalassemia patients in southern Iran.
    Karimi M; Nikrooz P; Kashef S; Jamalian N; Davatolhagh Z
    Int J Lab Hematol; 2007 Oct; 29(5):321-6. PubMed ID: 17824911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.